Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)

Clinical trial NCT05520619 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05520619
Sponsor: Sun Yat-sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma Locally Advanced Esophageal Squamous Cell Carcinoma

Start date: 2022-09-15
Primary completion: 2025-11-10
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.